Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026)
Repligen (RGEN) reported Non-Current Deferred Tax Liability of $15.0 million for Q1 2026, down 37.78% year-over-year from $24.1 million in Q1 2025, and down 33.24% quarter-over-quarter from $22.5 million in Q4 2025.
Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Repligen (RGEN) has 15 years of Non-Current Deferred Tax Liability data on file, last reported at $15.0 million in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $15.0 million, down 37.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.0 million (down 37.78% YoY), and the FY2025 annual result was $22.5 million, down 1.23% from the prior year.
- Non-Current Deferred Tax Liability declined to $15.0 million in Q1 2026 per RGEN's latest filing, from $22.5 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $39.3 million in Q4 2023 and troughed at $14.5 million in Q3 2023.
- A 5-year average of $25.1 million and a median of $23.3 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 131.93% in 2024 and fell as far as 42.08% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $23.0 million in 2022, then soared by 70.97% to $39.3 million in 2023, then tumbled by 42.08% to $22.8 million in 2024, then decreased by 1.23% to $22.5 million in 2025, then plunged by 33.24% to $15.0 million in 2026.
- Business Quant data shows RGEN's Non-Current Deferred Tax Liability at $15.0 million in Q1 2026, $22.5 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.02 Mn |
| Mar 31, 2026 | 15.02 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 20.14 Mn |
| Sep 30, 2025 | 20.14 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Sep 30, 2024 | 33.69 Mn |
| Sep 30, 2024 | 33.69 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Mar 31, 2024 | 36.81 Mn |
| Mar 31, 2024 | 36.81 Mn |
| Dec 31, 2023 | 39.32 Mn |
| Dec 31, 2023 | 39.32 Mn |